<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T05:27:35Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/20500" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/20500</identifier><datestamp>2026-09-24T08:00:43Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Larché, Mark</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Singh, Tarandeep</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences (Molecular Virology and Immunology Program)</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2016-09-23T19:55:52Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2016-09-23T19:55:52Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2016</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/20500</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/20988</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Exposure to sufficiently high allergen levels of some allergens appears to protect&#xd;
against the development of allergic diseases, and has also been used to treat&#xd;
established allergic diseases. A reduced prevalence of sensitization and, in some&#xd;
cases, asthma was reported among individuals living in homes with high allergen&#xd;
levels. Furthermore, allergic patients treated with high allergen doses during&#xd;
immunotherapy experienced improved allergic symptoms. The mechanisms for&#xd;
how high allergen exposure may prevent disease are not known and thus, a model&#xd;
in which these mechanisms could be studied in detail is warranted. The objective&#xd;
of this thesis was to model and further characterize the phenomenon of high&#xd;
allergen dose-dependent protection against the development of allergic responses,&#xd;
using a mouse model of epicutaneous sensitization. The impact of exposure to a&#xd;
high dose of cat dander in established allergic disease was also evaluated.&#xd;
Epicutaneous exposure to a high dose of cat dander (150 μg) prevented airway&#xd;
inflammation and airway hyperresponsiveness in genetically different strains of&#xd;
mice, including Th2 prone BALB/c mice. The protective effects against airway&#xd;
inflammation appeared to wane between 10 and 120 days after exposure. When&#xd;
the high dose of cat dander was applied with a sensitizing dose of peanut, peanut induced anaphylaxis was prevented. Exposure to a high dose of another allergen,&#xd;
ovalbumin, was also able to prevent the development of allergic airway disease.&#xd;
In contrast, the high dose of cat dander did not improve established states of&#xd;
allergic disease. Thus, in our mouse model, a high dose of cat dander prevented&#xd;
the development of allergic responses and reflected characteristics of the&#xd;
phenomenon reported in humans. As such, this model may be useful for&#xd;
investigating mechanisms and potential prophylactic options for allergic diseases.&#xd;
As the high dose of cat dander either had no effect or worsened established&#xd;
allergic responses in our model, it is possible that the dose was not high enough to&#xd;
improve disease in sensitized mice. It is also possible that established disease&#xd;
cannot be modified by epicutaneous exposure.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Allergy</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">immunology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">eosinophils</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The impact of the dose and timing of epicutaneous allergen exposure on the manifestation of allergic responses in vivo</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative" lang="en_US">The effect of allergen dose on allergic responses</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>